Scientific & Strategic Partnerships

Our  team works with small to midsize pharmaceutical and biotechnology companies to help them achieve their drug development goals. We partner closely with clients to understand their unique challenges and connect them with the right scientific and regulatory expertise to help advance their programs. With offices in Canada and the US, the team is 40 full-time, in-house scientists who bring extensive experience and expertise in addressing complex toxicological issues, regulatory requirements, and drug development challenges across both the Canadian and U.S. markets. All of our Vice Presidents at Intrinsik within the pharmaceutical and biotechnology group have worked together for over two decades, and our team focuses on cultivating and nurturing relationships with both new and existing clients, while providing strategic support throughout the drug development lifecycle. We support the development of small molecules, biologics and advance cell and gene therapies from the preclinical stage through clinical development, regulatory submission, market approval, and the post-approval phase.

Services

• Regulatory Affairs Consulting
• Nonclinical Consulting
• Medical Writing
• Chemistry, Manufacturing & Controls (CMC) Writing
• Regulatory Operations
• Toxicological Consulting
• Due Diligence & Expert Support